Rhythm Biosciences Director Increases Stake
Company Announcements

Rhythm Biosciences Director Increases Stake

Rhythm Biosciences Ltd. (AU:RHY) has released an update.

Rhythm Biosciences Ltd has issued a formal notification about changes in the holdings of director Otto Buttula, indicating a recent on-market purchase of 600,000 RHY ordinary shares through an indirect interest, resulting in a total of 13,905,407 shares held after the transaction. The acquisition by Newfound Investments Pty Ltd, one of the director’s indirect investments, was valued at $40,408.89.

For further insights into AU:RHY stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App